Logan Wink

4.0k total citations
53 papers, 1.6k citations indexed

About

Logan Wink is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Genetics. According to data from OpenAlex, Logan Wink has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cognitive Neuroscience, 25 papers in Psychiatry and Mental health and 24 papers in Genetics. Recurrent topics in Logan Wink's work include Autism Spectrum Disorder Research (44 papers), Genetics and Neurodevelopmental Disorders (23 papers) and Child Nutrition and Feeding Issues (16 papers). Logan Wink is often cited by papers focused on Autism Spectrum Disorder Research (44 papers), Genetics and Neurodevelopmental Disorders (23 papers) and Child Nutrition and Feeding Issues (16 papers). Logan Wink collaborates with scholars based in United States and Norway. Logan Wink's co-authors include Craig A. Erickson, Christopher J. McDougle, Ernest V. Pedapati, Rebecca C. Shaffer, Maureen Early, Sarah E. Fitzpatrick, Tori L. Schaefer, Paul S. Horn, Kimberly A. Stigler and David J. Posey and has published in prestigious journals such as Brain Research, Journal of the American Academy of Child & Adolescent Psychiatry and Psychopharmacology.

In The Last Decade

Logan Wink

50 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Logan Wink United States 24 1.2k 658 597 400 294 53 1.6k
Roberto Canitano Italy 23 1.0k 0.8× 772 1.2× 474 0.8× 294 0.7× 376 1.3× 46 1.7k
Stephen J. Guter United States 18 988 0.8× 725 1.1× 365 0.6× 155 0.4× 283 1.0× 26 1.3k
Robin A. Libove United States 19 994 0.8× 381 0.6× 375 0.6× 471 1.2× 139 0.5× 27 1.6k
Janita Bralten Netherlands 22 749 0.6× 324 0.5× 672 1.1× 203 0.5× 198 0.7× 55 1.4k
Raffaella Tancredi Italy 25 1.2k 1.0× 556 0.8× 499 0.8× 327 0.8× 361 1.2× 60 1.7k
Jessica A. Hellings United States 22 1.1k 0.9× 411 0.6× 879 1.5× 440 1.1× 214 0.7× 47 2.1k
Erik J. Mulder Netherlands 15 738 0.6× 354 0.5× 306 0.5× 322 0.8× 135 0.5× 24 1.1k
Marilena M. DeMayo Australia 10 712 0.6× 235 0.4× 306 0.5× 286 0.7× 87 0.3× 26 1.0k
Jaswinder K. Ghuman United States 23 1.2k 1.0× 308 0.5× 1.3k 2.1× 717 1.8× 129 0.4× 34 1.9k
Bertine Lahuis Netherlands 11 667 0.6× 305 0.5× 405 0.7× 201 0.5× 94 0.3× 16 954

Countries citing papers authored by Logan Wink

Since Specialization
Citations

This map shows the geographic impact of Logan Wink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Logan Wink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Logan Wink more than expected).

Fields of papers citing papers by Logan Wink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Logan Wink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Logan Wink. The network helps show where Logan Wink may publish in the future.

Co-authorship network of co-authors of Logan Wink

This figure shows the co-authorship network connecting the top 25 collaborators of Logan Wink. A scholar is included among the top collaborators of Logan Wink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Logan Wink. Logan Wink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sadhwani, Anjali, Anne Wheeler, Sarika U. Peters, et al.. (2024). Developmental milestones and daily living skills in individuals with Angelman syndrome. Journal of Neurodevelopmental Disorders. 16(1). 32–32. 1 indexed citations
2.
Erickson, Craig A., Charles R. Tessier, Christina Groß, et al.. (2023). Lymphocytic Extracellular Signal–Regulated Kinase Dysregulation in Autism Spectrum Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 62(5). 582–592.e2. 3 indexed citations
3.
Wink, Logan, Paul S. Horn, Rebecca C. Shaffer, et al.. (2020). Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder—Initial Results of a Randomized, Controlled, Crossover, Pilot Study. Journal of Autism and Developmental Disorders. 51(4). 1392–1399. 19 indexed citations
4.
Fitzpatrick, Sarah E., Lauren Schmitt, Ryan Adams, et al.. (2019). Pediatric Quality of Life Inventory (PedsQL) in Fragile X Syndrome. Journal of Autism and Developmental Disorders. 50(3). 1056–1063. 5 indexed citations
5.
Dominick, Kelli C., Logan Wink, Ernest V. Pedapati, et al.. (2018). Risperidone Treatment for Irritability in Fragile X Syndrome. Journal of Child and Adolescent Psychopharmacology. 28(4). 274–278. 10 indexed citations
6.
Wink, Logan, Ernest V. Pedapati, Ryan Adams, et al.. (2017). Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 48(11). 3711–3719. 12 indexed citations
7.
Hong, Michael, Logan Wink, Ernest V. Pedapati, et al.. (2017). Eye gaze and pupillary response in Angelman syndrome. Research in Developmental Disabilities. 68. 88–94. 17 indexed citations
8.
Wink, Logan, Noha F. Minshawi, Rebecca C. Shaffer, et al.. (2017). d-Cycloserine enhances durability of social skills training in autism spectrum disorder. Molecular Autism. 8(1). 2–2. 34 indexed citations
9.
Wink, Logan, Ryan Adams, Zemin Wang, et al.. (2016). A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder. PMC.
10.
Wink, Logan, et al.. (2016). Weight Gain Effects of Second-Generation Antipsychotic Treatment in Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 26(9). 822–827. 35 indexed citations
11.
Minshawi, Noha F., Logan Wink, Rebecca C. Shaffer, et al.. (2016). A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders. Molecular Autism. 7(1). 2–2. 53 indexed citations
12.
Wink, Logan, et al.. (2016). Clozapine for Drug-Refractory Irritability in Individuals with Developmental Disability. Journal of Child and Adolescent Psychopharmacology. 26(9). 843–846. 12 indexed citations
13.
Pedapati, Ernest V., Donald L. Gilbert, Craig A. Erickson, et al.. (2016). Abnormal Cortical Plasticity in Youth with Autism Spectrum Disorder: A Transcranial Magnetic Stimulation Case–Control Pilot Study. Journal of Child and Adolescent Psychopharmacology. 26(7). 625–631. 21 indexed citations
14.
Wink, Logan, Ernest V. Pedapati, Paul S. Horn, Christopher J. McDougle, & Craig A. Erickson. (2015). Multiple Antipsychotic Medication Use in Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 27(1). 91–94. 18 indexed citations
15.
Dominick, Kelli C., Logan Wink, Christopher J. McDougle, & Craig A. Erickson. (2015). A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 25(5). 397–401. 22 indexed citations
16.
Wink, Logan, Maureen Early, Tori L. Schaefer, et al.. (2014). Body Mass Index Change in Autism Spectrum Disorders: Comparison of Treatment with Risperidone and Aripiprazole. Journal of Child and Adolescent Psychopharmacology. 24(2). 78–82. 58 indexed citations
17.
Vasa, Roma A., Laura M. Carroll, Alixandra A. Nozzolillo, et al.. (2014). A Systematic Review of Treatments for Anxiety in Youth with Autism Spectrum Disorders. Journal of Autism and Developmental Disorders. 44(12). 3215–3229. 104 indexed citations
18.
Erickson, Craig A., Maureen Early, Kimberly A. Stigler, et al.. (2011). An Open-Label Naturalistic Pilot Study of Acamprosate in Youth with Autistic Disorder. Journal of Child and Adolescent Psychopharmacology. 21(6). 565–569. 45 indexed citations
19.
Erickson, Craig A., Kimberly A. Stigler, Logan Wink, et al.. (2011). A prospective open-label study of aripiprazole in fragile X syndrome. Psychopharmacology. 216(1). 85–90. 51 indexed citations
20.
Wink, Logan, Martin H. Plawecki, Craig A. Erickson, Kimberly A. Stigler, & Christopher J. McDougle. (2010). Emerging drugs for the treatment of symptoms associated with autism spectrum disorders. Expert Opinion on Emerging Drugs. 15(3). 481–494. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026